← All trials
NCT05597436
N/AExpanded Access
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- —
- Primary completion
- —
- Completion date
- —
- First posted
- Oct 28, 2022
- Last posted
- Dec 19, 2022
- Enrollment
- —
- Arms / groups
- — / —
- Source
- AACT · ctgov ingestion
Sponsors
- Seelos TherapeuticsLead sponsor
- Harvard UniversityCollaborator
- Harvard UniversityOverall official - principal investigator
- National Institute of Neurological Disorders and Stroke (NINDS)Collaborator
- National Institutes of Health (NIH)Collaborator
- Harvard UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.